A Study of Lomvastomig (RO7121661) and Tobemstomig (RO7247669) Compared With Nivolumab in Participants With Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus
Clinical trial NCT04785820 · COMPLETED
Trial details
- NCT number
- NCT04785820
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-25
- Primary completion
- 2025-01-30
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.